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Abstract: Reducttve cycliration of the aztdo epoxides 19a and 19/3followed by &protection afforded the HN 
rnkbttor (+)-7-eptatutraline 7 ar(d (-)-‘l-epialextne 9. The formatwn of 7 proceeded with an unusual tnverston of 
configuratton at C-7. 
Polyhydroxylated indolizidine alkaloids such as castanospermine 1 and swainsonine 2 have attracted 
considerable interest in recent years due to their ability to inhibit glycosidases.1 In addition to their use in the 
study of glycoprotein-processing enzymes, such alkaloids are promising anticancer and antrretrovnal agents. 
More recently, polyhydroxylated pyrrolizidine alkaloids with similar biological activities have emerged from the 
independent investigations of research teams in the U.K. and the U.S.A. The isolation of alexine 3 from Alexa 
leiopetala was reported in 1988.2 The isolation of similar alkaloids from Castanospetmwn australe quickly 
followed, including 3,7a-diepialexine (or 3-epiaustraline) 4,3,4 australine 5,5 I-epiaustraline (or 1,7a- 
dieptalexine) 6,6*7 and 7,7a-diepialexme (or 7-epiaustraline) 7 .7 While alexine 3 and 3-eptaustraline 4 are 
generally poor inhibitors of glucosidases and galactosidases,*,4 they display a m lo y g lucostdase inhibition which 
is on par with that of castanospermine,7 and alexine is an effective thioglucosidase inhibitor.8 Compounds 5-7 
are also good amyloglucosidase inhibitors. 5,779 Australine 5 inhibits glucosidase I, but not glucosidase II,9 and 
has recently been shown to exhibit antiviral activity. 10 Modest glucosidase I, g-glucosidase, and rx-mannosidase 
inhibition was observed for I-epiaustraline 6.6 but it displayed good acttvity in a mouse gut digestive a- 
glucosidase assay, as did 7-epiaustmliie 7. 7.11 An exciting recent report shows that australme 5, l- 
epiaustraline 6, and 7-epiaustraline 7 inhibit HIV-induced syncytia formation in N cells1 1 The potential of the 
polyhydroxylated pyrrolizidine alkaloids as selective glycosidase inhibitors and as antiviral and antiretrovtral 
agents makes them attractive targets for synthesis. In particular, the ability to prepare alternative stereoisomers 
of these alkaloids would be desirable, since the biological activity of these compounds varies substantially with 
their stereochemistry. We wish to report our initial efforts in this area, which have led to the synthesis of the 
naturally occurring alkaloid (+)-7-epiaustraline 7 (also known as 7,7a_diepialexme) which shows anti-HIV 
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acuvtty,tl and the non-natural compound (-)-7-epialexine 9. 12 Our syntheses of 7 confirms tts absolute 
configuration.7 
Synthetic efforts on the polyhydroxylated pyrrohztdtne alkaloids have been sparse to date.13 In 1988, 
Fleet reported the synthesis of alexme 3 and the two non-natural alkaloids 3-epialexine 8 and 7-epialextne 9 
from glucose.t2 Fleet has now completed the synthesis of 6 and the non-natural alkaloid 1,7,7a-ttieptalexine 
(or 1,7_d:epiaustraline) 10.14 Syntheses of related pynolizidine alkaloids without the 3-hydroxymethyl group 
have also been reported.lsJe 
We have recently reported that compounds such as 11 undergo tandem epoxide openmg/intramolecular 
alkylatton to produce indobznhnes 12 (n=2). t7-t9 The relative stereochemistry of the two newly formed 
stereocenters should be determined ulnmately by the geometry of the alkene which is a precursor to 11 We 
now report that this strategy is useful for pyrrobzidme synthesis (12, n=l), and that the stereochemical outcome 







Our synthesis began with 2,3,5-tri-O-benzyl-L-xylofuranose 13, *ua whtch was prepared from L-xylose 
in 3 steps.*on Wittig olefination produced 14, which was converted to aztde 15 by displacement of a mflate 
wtth aztde ton. The aztde 15 was quote unstable, and underwent an nnramolecular 1,3dipolar cycloaddition 
upon standing at room temperature. Hence, tt was best to carry 15 to the next step without delay. Ozonolysis 
of 15 afforded the aldehyde 16, which was not punfied due to us sensittvity, but was duectly converted to the 
Z-alkene 17 by a very stereoselecttve Wttttg reaction with a silyloxy-substituted ylide.21 Again, tntramolecular 
1,3-dipolar cycloadditton was observed tf this azldoalkene was allowed to stand at room temperature. 
Epoxidation of the 17 with mCPBA produced a 1.1 mixture of epoxides 18a and 18/3, whtch were not 
separated 22 Tosylation of 18aQ gave 19aih as a 2.1 mixture of isomers, since one of the tsomers of 18 
underwent tosylatton faster than the other, and the reaction could not be driven to complenon Reducnon of 
19&p without debenzylation was possible by hydrogenolysis. The resultant amme was not Isolated but was 
directly heated m refluxing EtOH contaimng K$D3, affordmg a 2.1 mtxture of two pyrrolizidmes 20 and 21 
which were easily separated by flash chromatography At this point, the stereochemistry of20 and 21 was 
unknown, but it was assumed that the methane hydrogens at C-7 and C-7a were cis tn both isomers due to then 
CIS relationship in alkene 17 and epoxldes 18 and 19. Hydrogenolysls of the benzyl ethers of the separated 
pyrrolizidines 20 and 21 usmg a greater amount of palladtum catalyst afforded two tetrahydroxypyrrohzldlnes, 
which were found to be (+)-7-epiaustraline 7 and (-)-7-epialextne 9 by comparison of their physical and spectral 
data to hterature values, mcludtng optical rotation ‘*I2 The formatton of 7 was unexpected, smce the methine 
hydrogens at C-7 and C-7a were hzns rather than CU. We had expected australme 4 to result from the 
cychzation of 19a. Isomenzation of the alkene 17 or the epoxides 18 and 19 from CIS to frans dunng then 
manipulation was ruled out by 1H NMR spectroscopy. Gtven that the stereochemistry of the centers at Cl-C3 1s 
based on L-xylose, there are only four possible structures that may arise upon cychzatton of the amtnoepoxides 
19. 3,5, 7, and 9. Since the structures of 3, 5, and 9 have been established by X-ray crystallography2~~~t2 
and since our data for 7 are not consistent with these structures, it appears that the asstgnment of 7 must be as 
shown. The literature assignment of 7 rests on NOE experiments and comparison wtth known structures.7 The 
absolute stereochemistry was not determined, but was proposed to be as shown The unusual mverston of 
configuration at C-7 which occurs in the formatton of 7 IS currently under mvesttgauon 
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In summary, a relatively short route to (+)-7-epiaustrahne 7 and (-)-7-epialexine 9 has been developed. 
The absolute stereochemistry of the anti-HIV alkaloid 7 has been confvmed to be as shown based on the 
stereochemistry of L-xylose. While the use of the tandem aminoepoxide opening/iitramolecular alkylation 
approach is efficient, caution must be used in predicting the stereochemical outcome of this reaction. 
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19a + 19p (2.1,77%)* 




(a) 2 2 eq PhsP+CHsBi + 2.3 eq n-Bull, THF, 
0 “C, 15 mtn. then add 13 at -78’C, warm to 
23’ C over 3h (b) 1.2 eq TfaO, 1.4 eq pyr, 
CHaCla, -40’ C to 0’ C. 2 5h, 5 eq Bu4NNs. 
PhH, 23’ C, ih (c) 03, CHsCls/CHsOH (6 I), 
Sudan Ill (0 l%), -78°C 3 eq Me2S, -78’ C to 
23’ C, 3 5h (d) 1 05 eq PhsP+(CHs)sOH Bi, 
2 1 eq KN(SiMes)a, THF, 0’ C, 1 h, 23’C, lh, 
7 (87%) 9 (87%) 
1 68 eq Me3SrCI, 0’ C, 10 mm, add 16, -78’C, 
(t)-7-epraustralrne (-)-7-epralexrne 
lh,23°C,lh,lMHCI,230C,lh (e)15eq 
mCPBA, CH2C12, 0” C, 23’ C, 24h (1) 2 eq pTsCI, 3 eq pyr, 0 1 eq DMAP, CHpClp, -15’ C, 48h ‘Based on 12% 
recovered 18 (g) 5 wt % of 10% Pd/C, EtsO/EtOH (2 1). 1 atm HP, 23’ C, 15h, filter, add 6 eq KsCO3, EtOH, 
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